Patterns of cortical grey matter thickness reduction in multiple sclerosis.
MRI
cluster analysis
cortical gray matter
multiple sclerosis
temporal pole
Journal
Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
revised:
07
01
2021
received:
06
10
2020
accepted:
17
01
2021
pubmed:
29
1
2021
medline:
1
7
2021
entrez:
28
1
2021
Statut:
ppublish
Résumé
To examine the patterns of cortical gray matter thickness in multiple sclerosis (MS) patients. Seventy-four MS patients-clinically isolated syndrome (4%), relapsing-remitting MS (79%), and progressive MS (17%)-and 21 healthy controls (HCs) underwent 1.5 Tesla T1-weighted 3D MRI examinations to measure brain cortical thickness in a total of 68 regions of interest. Using hierarchical cluster analysis with multivariate cortical thickness data, cortical thickness reduction patterns were cross-sectionally investigated in MS patients. The MS patients were grouped into three major clusters (Clusters 1, 2, and 3). Most of the regional cortical thickness values were equivalent between the HCs and Cluster 1, but decreased in the order of Clusters 2 and 3. Only the thicknesses of the temporal lobe cortices (the bilateral superior and left middle temporal cortex, as well as the left fusiform cortex) were significantly different among Clusters 1, 2, and 3. In contrast, temporal pole thickness reduction was evident exclusively in Cluster 3, which was also characterized by increased lesion loads in the temporal pole and the adjacent juxtacortical white matter, dilatation of the inferior horn of the lateral ventricle, severe whole-brain volume reduction, and longer disease duration. Although cortical atrophy was significantly more common in the progressive phase, approximately half of the MS patients with the severe cortical atrophy pattern had relapsing-remitting disease. Cortical thickness reduction patterns in MS are mostly characterized by the degree of temporal lobe cortical atrophy, which may start in the relapsing-remitting phase. Among the temporal lobe cortices, the neurodegenerative change may accelerate in the temporal pole in the progressive phase.
Identifiants
pubmed: 33506628
doi: 10.1002/brb3.2050
pmc: PMC8035454
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e02050Informations de copyright
© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Références
Eur Radiol. 2014 Sep;24(9):2334-43
pubmed: 24906701
Brain. 2017 Feb;140(2):457-471
pubmed: 28040670
Continuum (Minneap Minn). 2019 Jun;25(3):736-752
pubmed: 31162314
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Cereb Cortex. 2017 Jan 1;27(1):777-792
pubmed: 26604273
J Cogn Neurosci. 1993 Spring;5(2):162-76
pubmed: 23972151
Epilepsy Res Treat. 2012;2012:176157
pubmed: 22934160
Brain. 2005 Nov;128(Pt 11):2705-12
pubmed: 16230320
Neurology. 2013 Nov 12;81(20):1759-67
pubmed: 24122185
Brain. 2016 Jan;139(Pt 1):115-26
pubmed: 26637488
Neuroimage Clin. 2015 May 16;8:367-75
pubmed: 26106562
Neurology. 2017 Jan 24;88(4):403-413
pubmed: 27986875
Ann Neurol. 2018 Feb;83(2):208-209
pubmed: 29328526
J Neurol. 2015;262(4):831-6
pubmed: 25605435
Mult Scler Relat Disord. 2020 Oct;45:102388
pubmed: 32659734
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Neurol Neuroimmunol Neuroinflamm. 2015 Apr 09;2(3):e102
pubmed: 25884012
Brain Behav. 2021 Apr;11(4):e02050
pubmed: 33506628
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
IEEE Trans Med Imaging. 2007 Apr;26(4):518-29
pubmed: 17427739
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
J Neuroimmunol. 2017 May 15;306:68-75
pubmed: 28385190
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11050-5
pubmed: 10984517
Neurology. 2014 Nov 18;83(21):1936-44
pubmed: 25344382
Brain. 2011 Sep;134(Pt 9):2755-71
pubmed: 21840891
Eur J Neurol. 2018 Feb;25(2):334-339
pubmed: 29105222
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Nat Rev Neurol. 2020 Mar;16(3):171-182
pubmed: 32094485
J Neuroimaging. 2015 Nov-Dec;25(6):996-1001
pubmed: 25786805
Eur J Neurol. 2016 Jul;23(7):1165-73
pubmed: 27108769
Ann Neurol. 2019 May;85(5):653-666
pubmed: 30851128
N Engl J Med. 2018 Jan 11;378(2):169-180
pubmed: 29320652
IEEE Trans Med Imaging. 2001 Jan;20(1):70-80
pubmed: 11293693
Brain. 2007 Jul;130(Pt 7):1718-31
pubmed: 17392317
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Brain. 2009 Nov;132(Pt 11):2932-46
pubmed: 19762452
J Neurol. 2020 Feb;267(2):395-405
pubmed: 31654116
Brain. 2016 Mar;139(Pt 3):807-15
pubmed: 26912645
J Magn Reson Imaging. 2012 Jul;36(1):1-19
pubmed: 22696123
Mov Disord. 2016 May;31(5):699-708
pubmed: 27094093
Ann Neurol. 2018 Feb;83(2):210-222
pubmed: 29331092
Neurology. 2010 Jan 26;74(4):321-8
pubmed: 20101038
Neurology. 2011 Feb 1;76(5):418-24
pubmed: 21209373